Arkema announced an investment plan to increase by 25% ofPA12 product capacity, commercialized under the trademark Rilsamid®. This new capacity will be added at Arkema’s Changshu production base in China and is expected to put into production by mid-2020. With this latest investment plan, Arkema continues to reinforce its specialty polyamide business in all three major global regions-Europe, North America and now Asia. 　　This investment which represents several tens of millions of euros, will support the strong demand in growth applications such as cable protection, light weighting (metal replacement) in automobiles, improved high performance sports shoes and evolving applications in the consumer electronics segment. The mid-term growth rates in these applications are expected to exceed 7% per year in Asia.